(구)글로벌 핫이슈
핵의학
- 2017년 09월호[Clin Cancer Res.] Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models.
Bayer AG / Arne Scholz*2017 Aug 1댓글: 0조회수: 1475
- 2017년 09월호[Clin Cancer Res.] Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.
Erasmus Medical Center / Tessa Brabander*2017 Aug 15댓글: 0조회수: 1433
- 2017년 09월호[Clin Cancer Res.] Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.
Stanford University / Eben L. Rosenthal*2017 Aug 15댓글: 0조회수: 1413
- 2017년 09월호[Proc Natl Acad Sci U S A.] Bacterial infection imaging with [18F]fluoropropyl-trimethoprim.
University of Pennsylvania / Sellmyer MA*2017 Aug 1댓글: 0조회수: 1432
- 2017년 08월호[Cancer Res.] Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas.
Fred Hutchinson Cancer Research Center/ O'Steen S* 2017 Jul 15댓글: 0조회수: 1501
- 2017년 07월호[Lancet Neurol.] Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
Mayo Clinic / Clifford Jack Jr* 2017 Jun댓글: 1조회수: 1509
- 2017년 07월호[Cancer Res.] A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant.
Stanford University / Sanjiv Sam Gambhir* 2017 Jun 1댓글: 0조회수: 1489
- 2017년 07월호[Clin Cancer Res.] Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.
University of Groningen / Gooitzen M. van Dam* 2017 Jun 1댓글: 0조회수: 1418
- 2017년 07월호[Clin Cancer Res.] Bone Marrow Cell Trafficking Analyzed by 89Zr-oxine Positron Emission Tomography in a Murine Transplantation Model.
NIH / Noriko Sato* 2017 Jun 1댓글: 0조회수: 1404
- 2017년 07월호[Clin Cancer Res.] 18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.
Memorial Sloan Kettering Cancer Center / Gary A. Ulaner* 2017 Jun 15댓글: 0조회수: 1396
